Health · 3 views
STAT+: Mark Cuban wants to crack open the market for rare disease treatments
Mark Cuban's Cost Plus Drugs says it can reduce manufacturing costs for custom rare disease drugs and n-of-1 gene therapies.
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 3 Community interest
Brief read Under 1 min brief 20 words
AI Summary
Mark Cuban’s Cost Plus Drugs claims it can lower manufacturing costs for custom rare‑disease medicines and individualized (“n‑of‑1”) gene therapies.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- How the US organ transplant system works and what to ask to improve your chancesContinue reading
- States Are Forcing Hospitals To Offer More People Financial Aid. In Oregon, It’s Working.Continue reading
- Actor Christina Applegate says she was misdiagnosed with multiple sclerosisContinue reading
- Do women with postpartum psychosis receive adequate medical care?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow